Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Ambu A/S
  6. Summary
    AMBU B   DK0060946788

AMBU A/S

(AMBU B)
  Report
Delayed Nasdaq Copenhagen  -  10:59 2022-08-12 am EDT
77.00 DKK   -1.51%
08/04TRANSCRIPT : Ambu A/S, Q3 2022 Earnings Call, Aug 04, 2022
CI
08/03Preliminary results for Q3 2021/22, current trading (July) and launch of cost reduction program. Full-year 2021/22 guidance revised
GL
08/03Preliminary results for Q3 2021/22, current trading (July) and launch of cost reduction program. Full-year 2021/22 guidance revised
GL
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
08/08/2022 08/09/2022 08/10/2022 08/11/2022 08/12/2022 Date
73(c) 72.88(c) 72.4(c) 78.18(c) 77(c) Last
1 676 410 1 128 622 2 386 860 2 141 794 821 528 Volume
+3.63% -0.16% -0.66% +7.98% -1.51% Change
More quotes
Estimated financial data (e)
Sales 2022 4 395 M 606 M 606 M
Net income 2022 310 M 42,7 M 42,7 M
Net Debt 2022 1 320 M 182 M 182 M
P/E ratio 2022 64,1x
Yield 2022 0,36%
Sales 2023 5 314 M 732 M 732 M
Net income 2023 388 M 53,4 M 53,4 M
Net Debt 2023 1 302 M 180 M 180 M
P/E ratio 2023 51,2x
Yield 2023 0,51%
Capitalization 19 564 M 2 696 M 2 696 M
EV / Sales 2022 4,75x
EV / Sales 2023 3,93x
Nbr of Employees 5 000
Free-Float 65,7%
More Financials
Company
Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - single-use endoscopes (54%); - emergency care and resuscitation devices (24.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for... 
Read more
More about the company
Ratings of Ambu A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about AMBU A/S
08/04TRANSCRIPT : Ambu A/S, Q3 2022 Earnings Call, Aug 04, 2022
CI
08/03Preliminary results for Q3 2021/22, current trading (July) and launch of cost reduction..
GL
08/03Preliminary results for Q3 2021/22, current trading (July) and launch of cost reduction..
GL
08/03Ambu A/S Revises Earnings Guidance for the Full-Year 2021/2022
CI
07/27AMBU A/S : Q3 aide-mémoire file_download
PU
07/27Ambu Announces FDA Clearance of Fifth-Generation Single-Use Bronchoscope
CI
05/19Ambu Appoints New CEO; Shares Up 9%
MT
05/19Britt Meelby Jensen appointed new CEO of Ambu
GL
05/19Ambu A/S Reaffirms Earnings Guidance for the Fiscal Year 2021/22
CI
05/19Ambu A/S Announces Chief Executive Officer Changes
CI
05/06European shares suffer worst week in 2 months; tech, retail fall
RE
05/06TRANSCRIPT : Ambu A/S, Q2 2022 Earnings Call, May 06, 2022
CI
05/06AMBU A/S : Press Release
CO
05/06AMBU A/S : Half-year report
CO
05/05Interim report for Q2 2021/22 and the half-year
GL
More news
News in other languages on AMBU A/S
08/04POINT SUR LES FORTES VARIATIONS DU J : Royce n'est plus la Rolls, Ubisoft et Tencent parti..
08/03Ambu A/S révise ses prévisions de bénéfices pour l'ensemble de l'année 2021/2022
07/27Ambu annonce l'autorisation de la FDA pour son bronchoscope à usage unique de cinquième..
05/19Ambu nomme un nouveau PDG ; les actions sont en hausse de 9 %.
05/19Ambu A/S réaffirme ses prévisions de bénéfices pour l'exercice 2021/22
More news
Analyst Recommendations on AMBU A/S
More recommendations
Chart AMBU A/S
Duration : Period :
Ambu A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMBU A/S
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Last Close Price 77,00 DKK
Average target price 85,00 DKK
Spread / Average Target 10,4%
EPS Revisions
Managers and Directors
Britt Meelby Jensen Chief Executive Officer
Thomas Schmidt Chief Financial Officer
Jørgen Jensen Chairman
Måns Eskil Barsne Executive VP-Global Research & Development
Henrik Ankjær Executive Vice President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
AMBU A/S-55.49%2 696
ABBOTT LABORATORIES-20.79%195 226
MEDTRONIC PLC-8.34%125 988
BECTON, DICKINSON AND COMPANY7.29%75 203
HOYA CORPORATION-14.17%39 624
SARTORIUS STEDIM BIOTECH-20.96%36 037